# Mike Moradi

> Mike Moradi is a seed investor at Cortado Ventures backing Health Care. See 4 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [Cortado Ventures](https://shizune.co/investors/profile/cortado-ventures)
- Location: San Diego, United States
- Total investments: 4
- Last investment: Feb 2023
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: http://www.linkedin.com/in/mikemoradi
- X (Twitter): http://twitter.com/mikemoradi
- Facebook: http://www.facebook.com/mikemoradi

Mike Moradi is a seed investor at Cortado Ventures in San Diego focused on Health Care and Biotechnology. Mike Moradi is the Co-Founder & CEO at Sensulin.

## Contacts

5 contacts available for Mike Moradi: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/mike-moradi?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Biotechnology | 1 | 25% |
| Pharmaceutical | 1 | 25% |
| Outpatient Care | 1 | 25% |
| Machine Learning | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Convertible Note | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Moat Biotechnology | Based on the SC-AdVax platform that was exclusively licenced from the Mayo Clinic, Moat Biotechnology is a biopharmaceutical firm in the clinical development stage that is dedicated to the development of innovative intranasal and oral vaccines. | $6.5M | Venture - Series Unknown | Feb 09, 2023 |  |
| nSight Surgical | nSight is revolutionizing surgery with the first machine learning platform to ensure hospital patient safety and streamline operative workflow. By recognizing patient safety moments in the operating room, the platform improves patient safety and increases efficiency across the entire hospital ecosystem. | $1.1M | Seed | Nov 18, 2022 | https://www.nsightsurgical.ai/ |
| Moat Biotechnology | Based on the SC-AdVax platform that was exclusively licenced from the Mayo Clinic, Moat Biotechnology is a biopharmaceutical firm in the clinical development stage that is dedicated to the development of innovative intranasal and oral vaccines. |  | Seed | Sep 20, 2022 |  |
| Recuro Health | Recuro Health delivers value throughout the healthcare ecosystem with an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease focused model to a population health, outcomes approach. |  | Convertible Note | Mar 31, 2022 | https://recurohealth.com/ |

4 of 4 investments shown.

## Co-investors
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 1 deal together
- Boyd Street Ventures — VC Fund, 1 deal together
- Mammoth Scientific — VC Fund, 1 deal together

## About Cortado Ventures

VC Fund · Oklahoma City, United States

Cortado Ventures invest in capital-efficient businesses that leverage technology to scale in the fintech, biotech, aerospace, ag tech, and energy tech. It was founded in 2020 and headquartered in Oklahoma, United States. Intake form: https://cortado.ventures/contact-us/

3 contacts available at Cortado Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| David Woods | Co-Founder and Partner | https://shizune.co/investors/profile/david-woods-2be4 |
| Mike Moradi | Co-Founder & Venture Partner | https://shizune.co/investors/profile/mike-moradi |
| Nathaniel Harding | Managing Partner | https://shizune.co/investors/profile/nathaniel-harding |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Mike Moradi invest in?

Mike Moradi invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Seed and Convertible Note stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Mike Moradi?

Public channels for Mike Moradi include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Mike Moradi last invest?

The most recent investment recorded for Mike Moradi closed in Feb 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co